Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 308.56 million compared to CNY 357.55 million a year ago. Revenue was CNY 308.56 million compared to CNY 357.55 million a year ago.

Net income was CNY 6.96 million compared to CNY 5.79 million a year ago. Basic earnings per share from continuing operations was CNY 0.0072 compared to CNY 0.006 a year ago. Diluted earnings per share from continuing operations was CNY 0.0072 compared to CNY 0.006 a year ago.